Paternally expressed gene 3 (Peg3)3 was recently identified in our laboratory as a gene induced in the stroma of breast carcinoma xenografts following systemic delivery of decorin (1), a small leucine-rich proteoglycan with antioncogenic and antiangiogenic properties (2, –, 4). Here, DCN is linked to breast carcinoma.